In last trading session, Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) saw 0.55 million shares changing hands with its beta currently measuring -0.08. Company’s recent per share price level of $0.64 trading at -$0.05 or -6.00% at ring of the bell on the day assigns it a market valuation of $19.20M. That closing price of RVPH’s stock is at a discount of -962.5% from its 52-week high price of $6.80 and is indicating a discount of -3.13% from its 52-week low price of $0.66. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.33 million shares which gives us an average trading volume of 290.21K if we extend that period to 3-months.
For Reviva Pharmaceuticals Holdings Inc. (RVPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) trade information
Upright in the red during last session for losing -6.00%, in the last five days RVPH remained trading in the red while hitting it’s week-highest on Tuesday, 08/13/24 when the stock touched $0.64 price level, adding 26.68% to its value on the day. Reviva Pharmaceuticals Holdings Inc.’s shares saw a change of -87.50% in year-to-date performance and have moved -20.64% in past 5-day. Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) showed a performance of -40.37% in past 30-days. Number of shares sold short was 4.45 million shares which calculate 14.6 days to cover the short interests.
Reviva Pharmaceuticals Holdings Inc. (RVPH) estimates and forecasts
Statistics highlight that Reviva Pharmaceuticals Holdings Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -84.99% of value to its shares in past 6 months, showing an annual growth rate of 40.61% while that of industry is 18.90. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH)’s Major holders
Insiders are in possession of 16.58% of company’s total shares while institution are holding 23.66 percent of that, with stock having share float percentage of 28.36%. Investors also watch the number of corporate investors in a company very closely, which is 23.66% institutions for Reviva Pharmaceuticals Holdings Inc. that are currently holding shares of the company. WOODLINE PARTNERS LP is the top institutional holder at RVPH for having 1.06 million shares of worth $3.99 million. And as of 2024-03-31, it was holding 4.3897 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.0 million shares on 2024-03-31. The number of shares represents firm’s hold over 4.1685 of outstanding shares, having a total worth of $3.79 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2024 , the former fund manager was holding 700.44 shares of worth $0.45 million or 2.51% of the total outstanding shares. The later fund manager was in possession of 279.27 shares on Mar 31, 2024 , making its stake of worth around $0.18 million in the company or a holder of 1.00% of company’s stock.
